chr5-151025376-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_002084.5(GPX3):c.124G>A(p.Glu42Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000143 in 1,604,856 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 11/18 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_002084.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GPX3 | NM_002084.5 | c.124G>A | p.Glu42Lys | missense_variant | 2/5 | ENST00000388825.9 | NP_002075.2 | |
GPX3 | NM_001329790.2 | c.151G>A | p.Glu51Lys | missense_variant | 3/6 | NP_001316719.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GPX3 | ENST00000388825.9 | c.124G>A | p.Glu42Lys | missense_variant | 2/5 | 1 | NM_002084.5 | ENSP00000373477.4 |
Frequencies
GnomAD3 genomes AF: 0.0000592 AC: 9AN: 152040Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000288 AC: 7AN: 242996Hom.: 0 AF XY: 0.0000227 AC XY: 3AN XY: 132046
GnomAD4 exome AF: 0.0000103 AC: 15AN: 1452698Hom.: 0 Cov.: 31 AF XY: 0.0000111 AC XY: 8AN XY: 722658
GnomAD4 genome AF: 0.0000526 AC: 8AN: 152158Hom.: 0 Cov.: 32 AF XY: 0.0000403 AC XY: 3AN XY: 74378
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 10, 2024 | The c.124G>A (p.E42K) alteration is located in exon 2 (coding exon 2) of the GPX3 gene. This alteration results from a G to A substitution at nucleotide position 124, causing the glutamic acid (E) at amino acid position 42 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at